Godavari Drugs Ltd. Share Price & Stock Analysis

Godavari Drugs Ltd. (BSE: 530317) is a Secunderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹119 Cr, it ranks #3,106 by market cap among the 6,197 Indian listed companies on FinBizNet, and #67 of 86 in Medicinal Chemicals and Botanical Products. At ₹122.00 (as of 16 Nov 2026), the share price is 15.5% below its 52-week high of ₹144.35 and 75.0% above its 52-week low of ₹69.70. The share price is up 45.9% over one year and up 22.0% over three months.

Key Metrics

Current Price₹122.00
Market Cap₹119 Cr
BSE Code530317
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio21.8
Return on Equity6.87%
Return on Assets3.10%
52-Week Range₹69.70 – ₹144.35
1-Year Price Change+45.9%
3-Month Price Change+22.0%
Beta (1Y)0.47
HeadquartersSecunderabad, Telangana
Websitegodavaridrugs.com

Latest Quarterly Results — Q1 FY27

Revenue₹28 Cr
Net Profit₹1 Cr
Net Margin4.0%
EPS (Basic)₹1.10
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Godavari Drugs Ltd. Quarterly Revenue and Profit Trend

Godavari Drugs Ltd. reported revenue of ₹28 Cr in Q1 FY27, up 17.4% from ₹24 Cr in Q1 FY26 and down 15.7% from ₹33 Cr in Q4 FY26. It posted a net profit of ₹1 Cr for the quarter, against a net profit of ₹1 Cr in Q1 FY26 (up 6.7%). Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹22 Cr (Q3 FY26) to ₹33 Cr (Q4 FY26). The company was profitable in each of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹28 Cr₹1 Cr4.0%
Q4 FY26₹33 Cr₹1 Cr3.9%
Q3 FY26₹22 Cr₹1 Cr3.4%
Q2 FY26₹27 Cr₹1 Cr3.8%
Q1 FY26₹24 Cr₹1 Cr4.4%
Q4 FY25₹26 Cr₹1 Cr3.5%
Q3 FY25₹30 Cr₹1 Cr2.6%
Q2 FY25₹26 Cr₹1 Cr4.2%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 63.31% of Godavari Drugs Ltd.'s shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 89.5% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Godavari Drugs Ltd.

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.

Products and Services

1. Pharmaceuticals-This segment manufactures active pharmaceutical ingredients and its intermediates.

Business Segments

1. Manufacture and Sale of Active Pharmaceutical Ingredients (API) and its intermediates-100%

Godavari Drugs Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Godavari Drugs Ltd.₹119 Cr21.86.87%₹28 Cr+45.9%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Godavari Drugs Ltd.?

Godavari Drugs Ltd. is trading at ₹122.00, with a market capitalisation of ₹119 Cr.

Which sector does Godavari Drugs Ltd. belong to?

Godavari Drugs Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Godavari Drugs Ltd.?

Godavari Drugs Ltd. has a P/E of 21.8 and a return on equity of 6.87%.

What is the stock symbol of Godavari Drugs Ltd.?

Godavari Drugs Ltd. is listed on the BSE under the scrip code 530317.

How has Godavari Drugs Ltd.'s share price moved over the past year?

Godavari Drugs Ltd.'s share price is up 45.9% over one year and up 22.0% over three months. Its 52-week range is ₹69.70 to ₹144.35.

What were Godavari Drugs Ltd.'s latest quarterly results?

In Q1 FY27, Godavari Drugs Ltd. reported revenue of ₹28 Cr and net profit of ₹1 Cr, with basic EPS of ₹1.1 (standalone, parsed from the company's exchange filing).

How have Godavari Drugs Ltd.'s revenue and profit changed over the past year?

Godavari Drugs Ltd. reported revenue of ₹28 Cr in Q1 FY27, up 17.4% from ₹24 Cr in Q1 FY26 and down 15.7% from ₹33 Cr in Q4 FY26.

What is the promoter holding in Godavari Drugs Ltd.?

Promoters held 63.31% of Godavari Drugs Ltd.'s shares as of Mar 2026, unchanged from Mar 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.